Aspire BioPharma (ASBP) Cash From Investing

Annual CFI

-$75.90 K
+$4.82 M+98.45%

December 1, 2023

Summary

Performance

1-Year Change

+98.45%

3-Year Change

+98.45%

5-Year Change

+98.45%

15-Year Change

+98.45%

ASBP Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$75.90 K
ASBP annual cash flow from investing activities is currently at an all-time high

3-Year Low

-$4.90 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
ASBP previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
ASBP next annual earnings announcement has not yet been scheduled

OtherASBPcash flowmetrics:

Annual CFF

$0.00
ASBP annual cash flow from financing activities is $0.00

Annual CFO

$87.00 K
ASBP annual cash flow from operations is $87.00 thousand

Annual FCF

$11.10 K
ASBP annual free cash flow is $11.10 thousand

Annual CAPEX

-
ASBP annual capital expenditures value is unknown

Quarterly CFI

$0.00
+$38.30 K+100.00%

September 1, 2024

Summary

Performance

3-Month Change

+100%

1-Year Change

+100%

3-Year Change

+100%

5-Year Change

+100%

ASBP Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$0.00
ASBP quarterly cash flow from investing activities is currently at an all-time high

3-Year Low

-$38.30 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ASBP previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
ASBP next earnings announcement has not yet been scheduled

OtherASBPcash flowmetrics:

Quarterly CFF

$750.10 K
ASBP quarterly cash flow from financing activities is $750.10 thousand

Quarterly CFO

-$744.80 K
ASBP quarterly cash flow from operations is -$744.80 thousand

Quarterly FCF

-$744.80 K
ASBP quarterly free cash flow is -$744.80 thousand

Quarterly CAPEX

-
ASBP quarterly capital expenditures value is unknown

TTM CFI

-$38.30 K
$0.000.00%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

ASBP TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$38.30 K
ASBP TTM cash flow from investing activities is currently at an all-time high

3-Year Low

-$38.30 K
ASBP TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ASBP previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
ASBP next earnings announcement has not yet been scheduled

OtherASBPcash flowmetrics:

TTM CFF

$1.01 M
ASBP TTM cash flow from financing activities is $1.01 million

TTM CFO

-$955.80 K
ASBP TTM cash flow from operations is -$955.80 thousand

TTM FCF

-$994.00 K
ASBP TTM free cash flow is -$994.00 thousand

TTM CAPEX

-
ASBP TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ASBP Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+98.5%+100.0%0.0%
3 y3 years+98.5%+100.0%0.0%
5 y5 years+98.5%+100.0%0.0%

ASBP Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+6349.4%at high<-9999.0%at highat low
5 y5-yearat high+6349.4%at high<-9999.0%at highat low
alltimeall timeat high+6349.4%at high<-9999.0%at highat low

Aspire BioPharma Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(-100.0%)
-$38.30 K(0.0%)
Jun 2024
-
-$38.30 K(<-9900.0%)
-$38.30 K(0.0%)
Dec 2023
-$75.90 K
-
-
DateAnnualQuarterlyTTM
Sep 2023
-
$0.00(-100.0%)
-$38.30 K(0.0%)
Jun 2023
-
-$38.30 K
-$38.30 K
Dec 2022
-$4.90 M
-
-

FAQ

  • What is Aspire BioPharma annual cash flow from investing activities?
  • What is the all time high annual CFI for Aspire BioPharma?
  • What is Aspire BioPharma annual CFI year-on-year change?
  • What is Aspire BioPharma quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Aspire BioPharma?
  • What is Aspire BioPharma quarterly CFI year-on-year change?
  • What is Aspire BioPharma TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Aspire BioPharma?
  • What is Aspire BioPharma TTM CFI year-on-year change?

What is Aspire BioPharma annual cash flow from investing activities?

The current annual CFI of ASBP is -$75.90 K

What is the all time high annual CFI for Aspire BioPharma?

Aspire BioPharma all-time high annual cash flow from investing activities is -$75.90 K

What is Aspire BioPharma annual CFI year-on-year change?

Over the past year, ASBP annual cash flow from investing activities has changed by +$4.82 M (+98.45%)

What is Aspire BioPharma quarterly cash flow from investing activities?

The current quarterly CFI of ASBP is $0.00

What is the all time high quarterly CFI for Aspire BioPharma?

Aspire BioPharma all-time high quarterly cash flow from investing activities is $0.00

What is Aspire BioPharma quarterly CFI year-on-year change?

Over the past year, ASBP quarterly cash flow from investing activities has changed by +$38.30 K (+100.00%)

What is Aspire BioPharma TTM cash flow from investing activities?

The current TTM CFI of ASBP is -$38.30 K

What is the all time high TTM CFI for Aspire BioPharma?

Aspire BioPharma all-time high TTM cash flow from investing activities is -$38.30 K

What is Aspire BioPharma TTM CFI year-on-year change?

Over the past year, ASBP TTM cash flow from investing activities has changed by $0.00 (0.00%)